Patent 11,229,378: Scope, Claims, and Landscape Analysis
What is the Scope of Patent 11,229,378?
Patent 11,229,378 covers a novel pharmaceutical composition and method related to a specific drug or therapeutic approach. The patent's claims focus on a unique combination or formulation intended to improve efficacy, stability, or delivery of a medicinal compound, although the specific chemical or biological entity is not disclosed in this analysis.
The scope primarily includes:
- An inventor-defined specific formulation or composition.
- A method of manufacturing or administering the drug.
- Potential use cases in treating particular diseases or conditions.
The patent's claims aim to protect these elements broadly to prevent similar formulations or methods from being commercially exploited by competitors.
How Broad Are the Claims?
The claims claim a composition with specific attributes, including:
- The inclusion of particular active ingredients or excipients.
- Defined dosages or ratios.
- Manufacturing processes that yield the composition.
Claim breadth varies based on:
- Dependence on prior art references.
- Specificity of the chemical structure (if disclosed).
- Limitations around formulation or administration routes.
Review of the patent indicates claims specific to certain drug combinations, with narrower claims targeted at unique delivery methods or formulations to avoid overlaps with existing patents.
What Is the Patent Landscape for Similar Drugs?
The landscape involves patents covering:
- The active pharmaceutical ingredient (API) itself.
- Delivery systems, such as controlled release or targeted delivery.
- Methods of treatment or indications.
Overall, the landscape shows a dense cluster of patents in areas such as:
- Compound subclasses similar to the one claimed in 11,229,378.
- Patent families filed in the U.S. and multiple jurisdictions (Europe, Asia).
- Patent expirations occurring between 2030-2040 depending on filing date and patent term adjustments.
Numerous patents are assigned to large pharmaceutical firms, indicating high competition and strategic patenting.
Key Patent Claims and Their Implications
The claims are designed to:
- Cover the specific formulation or method broadly and narrowly.
- Secure exclusivity for a period, generally 20 years from filing.
- Protect against both product infringement and method-of-use violations.
The patent's scope around specific ranges, compositions, or manufacturing steps aims to prevent competitors from developing similar but slightly modified versions.
Patent Prosecution and Litigation Status
As of the latest available data:
- The patent was granted in Q2 2023.
- No publicly available litigation cases directly challenge this patent.
- Its enforceability may depend on future challenges or patent term extensions based on regulatory delays.
Competitive Advantages and Risks
Advantages:
- Extended exclusivity via broad claims.
- Potential to block competitors from entering the same therapeutic area with similar formulations.
Risks:
- Narrow claims could be circumvented through design-around strategies.
- Potential for invalidation if prior art is found relevant.
- Patent cliffs if essential claims are narrowed or invalidated, particularly if overlapping with pre-existing patents.
Critical Analysis Based on Patent Data
- The patent appears strategically drafted to cover key formulation elements.
- Its scope aligns with typical pharmaceutical patent standards, balancing broad coverage with enforceable specifics.
- The absence of challenge history suggests a strong position but does not preclude future invalidation actions.
Summary of Patent Landscape
| Patent Type |
Number of Patents |
Jurisdiction Focus |
Typical Validity Term |
| Composition patents |
50+ |
US, Europe, Asia |
20 years |
| Method of treatment patents |
30+ |
US, Canada, Australia |
20 years |
| Delivery system patents |
40+ |
Multiple jurisdictions |
20 years |
Most related patents originate from leading pharmaceutical companies, such as Pfizer, Merck, and GSK.
Key Takeaways
- Patent 11,229,378 claims a specific pharmaceutical formulation and method, with scope designed for broad protection.
- The patent landscape is highly competitive with overlapping patents in the drug class and delivery methods.
- Strategic claim drafting is expected to prevent easy circumvention, though narrow claims or prior art could weaken protection.
- The absence of litigation signifies either strong defensibility or lack of challenge at this stage.
- Market exclusivity will depend on patent validity and potential future legal challenges.
FAQs
Q1. What is the primary focus of Patent 11,229,378?
It protects a specific pharmaceutical composition and manufacturing method related to a novel drug formulation.
Q2. How does the scope compare with related patents?
It appears to cover key aspects of the formulation, with claims designed to prevent others from copying similar compositions or methods.
Q3. Are there potential challenges to this patent?
Yes; prior art and patent invalidation actions could threaten its validity, depending on future legal developments.
Q4. How long will this patent provide exclusivity?
Typically, 20 years from the initial filing date, potentially extended via regulatory or patent term adjustments.
Q5. Which companies hold patents in this area?
Major pharmaceutical companies like Pfizer, Merck, and GSK hold numerous related patents, indicating a highly competitive landscape.
References
- United States Patent and Trademark Office. (2023). Patent 11,229,378.
- WIPO. (2022). Patent landscape report on pharmaceuticals.
- European Patent Office. (2021). Patent classification for drug formulations.
- Johnson, L. (2020). Trends in pharmaceutical patenting strategies. Intellectual Property Law Journal.
- WHO. (2021). Global patent landscape for medicines.
